Hamdi A. Jama

发表

Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension.

C. Mackay, J. Muir, F. Marques, 2019, Hypertension.

Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial

P. Gibson, J. Muir, D. Kaye, 2021, Trials.

Population-Based Gut Microbiome Associations With Hypertension.

D. Kaye, F. Marques, Hamdi A. Jama, 2018, Circulation research.

Rodent models of hypertension

F. Marques, Hamdi A. Jama, G. Head, 2021, British journal of pharmacology.

The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immune-metabolism?

F. Marques, Hamdi A. Jama, A. Beale, 2019, Cardiovascular research.

Experimental Factors Influence Diversity Metrics of the Gut Microbiome in Laboratory Mice

D. Kaye, F. Marques, Hamdi A. Jama, 2023 .

Microbial Peer Pressure

F. Marques, Hamdi A. Jama, R. Muralitharan, 2020, Hypertension.

The gut microbiota and blood pressure in experimental models

D. Kaye, F. Marques, Hamdi A. Jama, 2019, Current opinion in nephrology and hypertension.

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial

C. K. Yao, D. Kaye, F. Marques, 2023, Nature Cardiovascular Research.

Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure

C. Mackay, D. Kaye, F. Marques, 2020, Scientific Reports.